ACET · Adicet Bio Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 4.89 USD |
|---|---|
| 1-day change | -4.3% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 3 / 7 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 20 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +36.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +70.6% |
| Market cap (USD) | $75.8M |